首站-论文投稿智能助手
典型文献
The comparison of survival between active surveillance or watchful waiting and focal therapy for low-risk prostate cancer:a real-world study from the SEER database
文献摘要:
To reduce treatment-related side effects in low-risk prostate cancer(PCa),both focal therapy and deferred treatments,including active surveillance(AS)and watchful waiting(WW),are worth considering over radical prostatectomy(RP).Therefore,this study aimed to compare long-term survival outcomes between focal therapy and AS/WW.Data were obtained and analyzed from the Surveillance,Epidemiology,and End Results(SEER)database.Patients with low-risk PCa who received focal therapy or AS/WW from 2010 to 2016 were included.Focal therapy included cryotherapy and laser ablation.Multivariate Cox proportional hazards models were used to compare overall mortality(OM)and cancer-specific mortality(CSM)between AS/WW and focal therapy,and propensity score matching(PSM)was performed to reduce the influence of bias and unmeasured confounders.A total of 19 292 patients with low-risk PCa were included in this study.In multivariate Cox proportional hazards model analysis,the risk of OM was higher in patients receiving focal therapy than those receiving AS/WW(hazard ratio[HR]=1.35,95%confidence interval[CI]:1.02-1.79,P=0.037),whereas no significant difference was found in CSM(HR=0.98,95%CI:0.23-4.11,P=0.977).After PSM,the OM and CSM of focal therapy and AS/WW showed no significant differences(HR=1.26,95%CI:0.92-1.74,P=0.149;and HR=1.26,95%CI:0.24-6.51,P=0.782,respectively).For patients with low-risk PCa,focal therapy was no match for AS/WW in decreasing OM,suggesting that AS/WW could bring more overall survival benefits.
文献关键词:
作者姓名:
Qi-Ming Yuan;Tian-Hai Lin;Kun Jin;Shi Qiu;Xiang-Hong Zhou;Di Jin;Jia-Kun Li;Lu Yang;Qiang Wei
作者机构:
Department of Urology,Institute of Urology,West China Hospital of Sichuan University,Chengdu 610041,China
引用格式:
[1]Qi-Ming Yuan;Tian-Hai Lin;Kun Jin;Shi Qiu;Xiang-Hong Zhou;Di Jin;Jia-Kun Li;Lu Yang;Qiang Wei-.The comparison of survival between active surveillance or watchful waiting and focal therapy for low-risk prostate cancer:a real-world study from the SEER database)[J].亚洲男性学杂志(英文版),2022(03):305-310
A类:
watchful,unmeasured
B类:
comparison,survival,between,active,surveillance,waiting,focal,low,risk,cancer,real,world,study,from,SEER,database,To,reduce,related,effects,PCa,both,deferred,treatments,including,AS,WW,worth,considering,radical,prostatectomy,RP,Therefore,this,aimed,compare,long,term,outcomes,Data,were,obtained,analyzed,Surveillance,Epidemiology,End,Results,Patients,who,received,included,Focal,cryotherapy,laser,ablation,Multivariate,Cox,proportional,hazards,models,used,overall,mortality,OM,specific,CSM,propensity,score,matching,PSM,was,performed,influence,bias,confounders,total,patients,In,multivariate,analysis,higher,receiving,than,those,ratio,confidence,interval,whereas,no,significant,After,showed,differences,respectively,For,decreasing,suggesting,that,could,bring,more,benefits
AB值:
0.455178
相似文献
Is oxygen therapy beneficial for normoxemic patients with acute heart failure? A propensity score matched study
Yue Yu;Ren-Qi Yao;Yu-Feng Zhang;Su-Yu Wang;Wang Xi;Jun-Nan Wang;Xiao-Yi Huang;Yong-Ming Yao;Zhi-Nong Wang-Department of Cardiothoracic Surgery,Changzheng Hospital,Naval Medical University,415 Fengyang Road,Huangpu District,Shanghai 200003,China;Trauma Research Center,Fourth Medical Center and Medical Innovation Research Department of the Chinese PLA General Hospital,51 Fucheng Road,Haidian District,Beijing 100048,China;Department of Burn Surgery,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Medical Research Center of War Injuries and Trauma,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Pathology,Changhai Hospital,Naval Medical University,Shanghai 200433,China
Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
Chunli Zhang;Wei Wan;Shuai Zhang;Jingwen Wang;Ru Feng;Jiangtao Li;Junyue Chai;Hebing Zhou;Liru Wang;Yuping Zhong;Xiaodong Mo;Mengzhu Shen;Hongmei Jing;Hui Liu-Department of Hematology,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China;Department of Hematology,Peking University Third Hospital,Beijing 100191,China;Department of Hematology,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China;Department of Hematology,Beijing No.6 Hospital,Beijing 100007,China;Department of Hematology,Beijing Luhe Hospital,Capital Medical University,Beijing 101100,China;Department of Hematology,Fuxing Hospital,Capital Medical University,Beijing 100038,China;Department of Hematology,Beijing Chao-Yang Hospital,Capital Medical University,Beijing 100043,China;Peking University People's Hospital,Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,Beijing 100044,China
Prognostic role of plasma levels of γ-glutamyl transpeptidase in patients with advanced gastric cancer treated with anti-PD-1 immunotherapy
Shaojie Xu;Yiming Feng;Xingyin Li;Zaozao Huang;Hewei Li;Ganxin Wang-First Clinical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Radiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Yangchunhu Community Hospital,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Department of Orthopedics,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
Prognostic nomogram incorporating radiological features for predicting overall survival in patients with AIDS-related non-Hodgkin lymphoma
Li Xueqin;Pan Ziang;Wang Xing;Hu Tianli;Ye Wen;Jiang Dongmei;Shen Wen;Liu Jinxin;Shi Yuxin;Xia Shuang;Li Hongjun-Radiological Department, Beijing You'an Hospital Affiliated of Capital Medical University, Beijing 100069, China;Neurological Department, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;Radiological Department, The Eighth People's Hospital of Guangzhou, Guangzhou, Guangdong 510060, China;Radiological Department, Shanghai Public Health Clinical Center, Affiliated of Fudan University, Shanghai 201058, China;Radiation Department, Tianjin First Central Hospital, Tianjin 300170, China;Radiological Department, Tianjin First Central Hospital, Tianjin 300192, China
Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
Shen Junyi;Qi Weili;Dai Junlong;Leng Shusheng;Jiang Kangyi;Zhang Yu;Ran Shun;Li Chuan;Wen Tianfu-Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Laboratory of Liver Transplantation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Chengdu University, Chengdu, Sichuan 610072, China;Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Leshan, Leshan, Sichuan 614700, China;Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, Chinese Academy of Sciences, Chengdu, Sichuan 610072, China;Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou 550000, China
Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer
Dan Lyu;Binliang Liu;Bo Lan;Xiaoying Sun;Lixi Li;Jingtong Zhai;Haili Qian;Fei Ma-Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Breast Cancer Medical Oncology,Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha 410013,China;Department of Medical Oncology,Cancer Hospital of Huanxing Chaoyang District,Beijing 100122,China;State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension
Huai-yu Wang;Suyuan Peng;Zhanghui Ye;Pengfei Li;Qing Li;Xuanyu Shi;Rui Zeng;Ying Yao;Fan He;Junhua Li;Liu Liu;Shuwang Ge;Xianjun Ke;Zhibin Zhou;Gang Xu;Ming-hui Zhao;Haibo Wang;Luxia Zhang;Erdan Dong-National Institute of Health Data Science at Peking University,Beijing 100191,China;Peking University Advanced Institute of Information Technology,Hangzhou 311215,China;Department of Nephrology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Clinical Nutrition,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Taikang Tongji(Wuhan)Hospital,Wuhan 430050,China;Renal Division,Department of Medicine,Peking University First Hospital,Peking University Institute of Nephrology,Beijing 100034,China;Peking-Tsinghua Center for Life Sciences,Beijing 100871,China;First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital;Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Ministry of Health;Key Laboratory of Molecular Cardiovascular Sciences,Ministry of Education;Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。